Philips Launches ECG AI Marketplace to Revolutionize Cardiac Diagnostics

Published: 22 Jul 2025

Author: Precedence Research

Share :

Royal Philips, a global leader in health technology, has announced the launch of its groundbreaking ECG AI Marketplace. The new marketplace enables hospitals and healthcare systems to access all artificial intelligence supplements for electrocardiogram (ECG) analysis in a single, effortless way. This allows for a single platform, making everything much easier to utilize and improving the accuracy of cardiovascular treatment.

The ECG AI Marketplace integrates several AI-driven algorithms of various vendors on the basis of the current infrastructure of Philips, such as IntelliSpace ECG system and cardiograph systems. This strategy aims to simplify the IT environment for hospital administrators and create opportunities that allow clinicians to explore the latest diagnostic solutions within a single system with built-in capabilities. The instruments arranged on the platform are the first certified instruments made by Anumana, a digital health company that provides AI-powered solutions in cardiac diagnostics. There is also their FDA-cleared algorithm to detect the low ejection fraction (LEF), one of the key signs of heart failure, made available to healthcare providers through the Philips ecosystem.

Additionally, the platform's ability to evolve ensures that no hospital has to continually reinvent its IT systems to maintain the highest standards of cardiological care. By increasing the number of AI developers entering the market and offering solutions to arrhythmias, ischemia, and other cardiac diseases, the platform will ultimately become a comprehensive, one-stop solution for cardiovascular diagnosis. Furthermore, the interoperability that Philips emphasizes also implies the easy work among departments and health networks to provide the data transportation directly and safely to make the decisions quicker.

Executive’s Statement

Simos Kedikoglou, M.D., President and COO, Anumana

“We’re proud to be the flagship offering on the Philips ECG AI Marketplace. Working with Philips expands access to our ECG-AI technology through a trusted platform, starting with our cleared LEF algorithm and extending to our full suite of point-of-care algorithms as they receive FDA regulatory clearance.”